back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-11 18:54 Tx date 2025-01-02 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$275.00
+11,000 vol $0.025 each |
700,000 | |
| Filed 2025-01-09 11:35 Tx date 2000-11-02 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$275.00
+11,000 vol $0.025 each |
||
| Filed 2025-02-14 12:43 Tx date 2025-02-10 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2025-02-14 12:40 Tx date 2024-10-29 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-09 11:36 Tx date 2025-01-09 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+100,000 vol $0.025 each |
800,000 | |
| Filed 2025-01-09 11:35 Tx date 2000-11-02 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$275.00
+11,000 vol $0.025 each |
11,000 | |
| Filed 2024-12-24 16:59 Tx date 2024-12-23 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2024-12-24 16:50 Tx date 2024-10-29 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-24 15:48 Tx date 2024-12-23 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
689,000 | |
| Filed 2024-12-20 17:47 Tx date 2024-12-19 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+68,000 vol $0.025 each |
189,000 | |
| Filed 2024-12-20 17:41 Tx date 2024-12-18 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,025
+121,000 vol $0.025 each |
121,000 | |
| Filed 2024-11-12 15:36 Tx date 2024-10-29 |
$SPOD
SPOD LITHIUM CORP. |
Goldstein, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-22 16:03 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+400,000 vol |
2,115,000 | |
| Filed 2022-02-22 15:59 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-400,000 vol $0.25 each |
-250,000 | |
| Filed 2022-02-21 10:22 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-21 10:10 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-10 15:35 Tx date 2022-02-10 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+200,000 vol $0.72 each |
1,715,000 | |
| Filed 2022-02-10 15:32 Tx date 2022-02-07 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,950
+110,000 vol $0.74 each |
1,515,000 | |
| Filed 2022-01-19 11:19 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
1,405,000 | |
| Filed 2022-01-19 11:17 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-50,000
-200,000 vol $0.25 each |
150,000 |